These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8025998)

  • 21. Impaired myocardial vasodilation during hyperemic stress with dipyridamole in hypertriglyceridemia.
    Yokoyama I; Ohtake T; Momomura S; Yonekura K; Nishikawa J; Sasaki Y; Omata M
    J Am Coll Cardiol; 1998 Jun; 31(7):1568-74. PubMed ID: 9626836
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heterogeneity of resting and hyperemic myocardial blood flow in healthy humans.
    Chareonthaitawee P; Kaufmann PA; Rimoldi O; Camici PG
    Cardiovasc Res; 2001 Apr; 50(1):151-61. PubMed ID: 11282088
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reproducibility of measurements of regional resting and hyperemic myocardial blood flow assessed with PET.
    Nagamachi S; Czernin J; Kim AS; Sun KT; Böttcher M; Phelps ME; Schelbert HR
    J Nucl Med; 1996 Oct; 37(10):1626-31. PubMed ID: 8862296
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Noninvasive PET quantitative myocardial blood flow with regadenoson for assessing cardiac allograft vasculopathy in orthotopic heart transplantation patients.
    Pampaloni MH; Shrestha UM; Sciammarella M; Seo Y; Gullberg GT; Botvinick EH
    J Nucl Cardiol; 2017 Aug; 24(4):1134-1144. PubMed ID: 28138813
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coronary vasodilator reserve, pain perception, and sex in patients with syndrome X.
    Rosen SD; Uren NG; Kaski JC; Tousoulis D; Davies GJ; Camici PG
    Circulation; 1994 Jul; 90(1):50-60. PubMed ID: 8026038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dipyridamole vasodilator response after human orthotopic heart transplantation: quantification by oxygen-15-labeled water and positron emission tomography.
    Rechavia E; Araujo LI; De Silva R; Kushwaha SS; Lammertsma AA; Jones T; Mitchell A; Maseri A; Yacoub MH
    J Am Coll Cardiol; 1992 Jan; 19(1):100-6. PubMed ID: 1729318
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coronary vasodilatory capacity and flow reserve in normal myocardium supplied by bypass grafts late after surgery.
    Campisi R; Czernin J; Karpman HL; Schelbert HR
    Am J Cardiol; 1997 Jul; 80(1):27-31. PubMed ID: 9205015
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myocardial blood flow response to pacing tachycardia and to dipyridamole infusion in patients with dilated cardiomyopathy without overt heart failure. A quantitative assessment by positron emission tomography.
    Neglia D; Parodi O; Gallopin M; Sambuceti G; Giorgetti A; Pratali L; Salvadori P; Michelassi C; Lunardi M; Pelosi G
    Circulation; 1995 Aug; 92(4):796-804. PubMed ID: 7641359
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitative relation between hemodynamic changes during intravenous adenosine infusion and the magnitude of coronary hyperemia: implications for myocardial perfusion imaging.
    Mishra RK; Dorbala S; Logsetty G; Hassan A; Heinonen T; Schelbert HR; Di Carli MF;
    J Am Coll Cardiol; 2005 Feb; 45(4):553-8. PubMed ID: 15708703
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vasodilator reserve in collateral-dependent myocardium as measured by positron emission tomography.
    McFalls EO; Araujo LI; Lammertsma A; Rhodes CG; Bloomfield P; Pupita G; Jones T; Maseri A
    Eur Heart J; 1993 Mar; 14(3):336-43. PubMed ID: 8458352
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Post COVID-19 syndrome with impairment of flow-mediated epicardial vasodilation and flow reserve.
    Verma A; Ramayya T; Upadhyaya A; Valenta I; Lyons M; Marschall J; Dehdashti F; Gropler RJ; Woodard PK; Schindler TH
    Eur J Clin Invest; 2022 Dec; 52(12):e13871. PubMed ID: 36083297
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Magnetic resonance-based assessment of global coronary flow and flow reserve and its relation to left ventricular functional parameters: a comparison with positron emission tomography.
    Schwitter J; DeMarco T; Kneifel S; von Schulthess GK; Jörg MC; Arheden H; Rühm S; Stumpe K; Buck A; Parmley WW; Lüscher TF; Higgins CB
    Circulation; 2000 Jun; 101(23):2696-702. PubMed ID: 10851206
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Variability of myocardial blood flow measurements by magnetic resonance imaging in the multi-ethnic study of atherosclerosis.
    Jerosch-Herold M; Vazquez G; Wang L; Jacobs DR; Folsom AR
    Invest Radiol; 2008 Mar; 43(3):155-61. PubMed ID: 18301311
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Repeatability of rest and hyperemic myocardial blood flow measurements with 82Rb dynamic PET.
    Manabe O; Yoshinaga K; Katoh C; Naya M; deKemp RA; Tamaki N
    J Nucl Med; 2009 Jan; 50(1):68-71. PubMed ID: 19091892
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impaired global myocardial flow dynamics despite normal left ventricular function and regional perfusion in chronic kidney disease: a quantitative analysis of clinical 82Rb PET/CT studies.
    Fukushima K; Javadi MS; Higuchi T; Bravo PE; Chien D; Lautamäki R; Merrill J; Nekolla SG; Bengel FM
    J Nucl Med; 2012 Jun; 53(6):887-93. PubMed ID: 22562499
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Severe impairment of coronary reserve during rejection in patients with orthotopic heart transplant.
    Nitenberg A; Tavolaro O; Loisance D; Foult JM; Benhaiem N; Cachera JP
    Circulation; 1989 Jan; 79(1):59-65. PubMed ID: 2642756
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of type 2 diabetes mellitus on epicardial adipose tissue volume and coronary vasomotor function.
    Chen WJ; Danad I; Raijmakers PG; Halbmeijer R; Harms HJ; Lammertsma AA; van Rossum AC; Diamant M; Knaapen P
    Am J Cardiol; 2014 Jan; 113(1):90-7. PubMed ID: 24169015
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Maximal coronary vasodilator capacity of orthotopic heart transplants in patients with and without rejection.
    Nitenberg A; Tavolaro O; Loisance D; Foult JM; Hittinger L; Aptecar E; Cachera JP
    Am J Cardiol; 1989 Sep; 64(8):513-8. PubMed ID: 2672759
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coronary vasodilatory capacity is impaired in patients with dilated cardiomyopathy.
    Weismüller S; Czernin J; Sun KT; Fung C; Phelps ME; Schelbert HR
    Am J Card Imaging; 1996 Jul; 10(3):154-62. PubMed ID: 8914701
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Persistent but reversible coronary microvascular dysfunction after bypass grafting.
    Spyrou N; Khan MA; Rosen SD; Foale R; Davies DW; Sogliani F; Stanbridge RD; Camici PG
    Am J Physiol Heart Circ Physiol; 2000 Dec; 279(6):H2634-40. PubMed ID: 11087215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.